Literature DB >> 27721646

Informed Assent Recall Among Adolescents in Substance Use Disorder Treatment Research.

Jordan P Davis1, Emily A Lux1, Douglas C Smith1, Leah Cleeland1.   

Abstract

Evidence suggests that vulnerable populations such as substance users, those involved in the criminal justice system, and those with cognitive deficits often fail to recall information regarding the informed assent process. This study investigated correlates of assent quiz errors (AQE) among adolescents enrolling in a substance use disorder treatment study.
METHOD: Adolescents (age 13-19) entering substance use treatment completed a standard informed consent procedure to participate in a longitudinal research study, followed by a brief 6-item assent quiz.
RESULTS: Informed assent quiz errors were lower in this study relative to those observed in the adult literature. Being male and having lower treatment resistance was associated with making an AQE. Both days of marijuana use and days spent in the criminal justice system were associated with AQE. Hyperactivity-impulsivity approached significance (p = .057) but was not a correlate of AQE.
CONCLUSION: Those collecting assent should be aware that heavily-using males involved in the criminal justice system are prone to make more errors, and should use procedures such as assent quizzes to enhance their understanding of study procedures. Future research should investigate the impact of motivation and consider using experimental designs to test adolescent recall of study procedures under various assenting conditions.

Entities:  

Keywords:  Capacity to consent; adolescent; assent; informed consent; research ethics; substance use treatment

Year:  2016        PMID: 27721646      PMCID: PMC5048739          DOI: 10.1080/1067828X.2015.1056866

Source DB:  PubMed          Journal:  J Child Adolesc Subst Abuse        ISSN: 1067-828X


  49 in total

Review 1.  Informed consent in clinical trials.

Authors:  F W Verheggen; F C van Wijmen
Journal:  Health Policy       Date:  1996-05       Impact factor: 2.980

2.  Adolescent Community Reinforcement Approach outcomes differ among emerging adults and adolescents.

Authors:  Douglas C Smith; Susan H Godley; Mark D Godley; Michael L Dennis
Journal:  J Subst Abuse Treat       Date:  2011-08-09

3.  Development and validation of the GAIN Short Screener (GSS) for internalizing, externalizing and substance use disorders and crime/violence problems among adolescents and adults.

Authors:  Michael L Dennis; Ya-Fen Chan; Rodney R Funk
Journal:  Am J Addict       Date:  2006

Review 4.  Parental consent in adolescent substance abuse treatment outcome studies.

Authors:  Douglas C Smith; Shamra Boel-Studt; Leah Cleeland
Journal:  J Subst Abuse Treat       Date:  2009-04-02

5.  Competency to consent to research: a psychiatric overview.

Authors:  P S Appelbaum; L H Roth
Journal:  Arch Gen Psychiatry       Date:  1982-08

6.  Impact of a training and certification program on the quality of interviewer-collected self-report assessment data.

Authors:  Janet C Titus; Douglas C Smith; Michael L Dennis; Melissa Ives; Laine Twanow; Michelle K White
Journal:  J Subst Abuse Treat       Date:  2011-12-03

7.  Do Research Intermediaries Reduce Perceived Coercion to Enter Research Trials Among Criminally Involved Substance Abusers?

Authors:  David S Festinger; Karen L Dugosh; Jason R Croft; Patricia L Arabia; Douglas B Marlowe
Journal:  Ethics Behav       Date:  2011

8.  Cross-validation of the alcohol and cannabis use measures in the Global Appraisal of Individual Needs (GAIN) and Timeline Followback (TLFB; Form 90) among adolescents in substance abuse treatment.

Authors:  Michael L Dennis; Rodney Funk; Susan Harrington Godley; Mark D Godley; Holly Waldron
Journal:  Addiction       Date:  2004-11       Impact factor: 6.526

Review 9.  Impulsivity as a determinant and consequence of drug use: a review of underlying processes.

Authors:  Harriet de Wit
Journal:  Addict Biol       Date:  2008-10-09       Impact factor: 4.280

10.  Some limits of informed consent.

Authors:  O O'Neill
Journal:  J Med Ethics       Date:  2003-02       Impact factor: 2.903

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.